A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
Public ClinicalTrials.gov record NCT00299546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa Monoclonal Antibody, Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis and Previously Treated With Biologic Anti- TNFa Agent(s)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of golimumab (CNTO 148) in subjects who have active rheumatoid arthritis and have been treated previously with at least 1 dose of a biologic anti-TNFa agent (etanercept, adalimumab or infliximab).
Study identification
- NCT ID
- NCT00299546
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 461 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2006 (Type not available)
- Primary completion
- Aug 2007 (Actual)
- Completion
- May 2012 (Actual)
- Last update posted
- Feb 27, 2014
2006 – 2012
United States locations
- U.S. sites
- 40
- U.S. states
- 22
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Paradise Valley | Arizona | — | — |
| Not listed | La Jolla | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Santa Monica | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Upland | California | — | — |
| Not listed | Trumbull | Connecticut | — | — |
| Not listed | Aventura | Florida | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Not listed | Jupiter | Florida | — | — |
| Not listed | Largo | Florida | — | — |
| Not listed | Palm Harbor | Florida | — | — |
| Not listed | Tamarac | Florida | — | — |
| Not listed | Moline | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Not listed | Cedar Rapids | Iowa | — | — |
| Not listed | Witchita | Kansas | — | — |
| Not listed | Louisville | Kentucky | — | — |
| Not listed | Wheaton | Maryland | — | — |
| Not listed | Boston | Massachusetts | — | — |
| Not listed | Rochester | Minnesota | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Syracuse | New York | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Wilmington | North Carolina | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Mayfield | Ohio | — | — |
| Not listed | Duncansville | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | West Reading | Pennsylvania | — | — |
| Not listed | Knoxville | Tennessee | — | — |
| Not listed | Fort Worth | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Lubbock | Texas | — | — |
| Not listed | Arlington | Virginia | — | — |
| Not listed | Spokane | Washington | — | — |
| Not listed | Brookfield | Wisconsin | — | — |
| Not listed | Racine | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00299546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 27, 2014 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00299546 live on ClinicalTrials.gov.